Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

DOI Web Site 44 Citations
  • Julio Rosenstock
    Dallas Diabetes Research Center at Medical City, Dallas, Texas
  • Vlado Perkovic
    George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia
  • Odd Erik Johansen
    Boehringer Ingelheim Norway KS, Asker, Norway
  • Mark E. Cooper
    Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
  • Steven E. Kahn
    Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle
  • Nikolaus Marx
    Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany
  • John H. Alexander
    Duke Clinical Research Institute, Duke Health, Durham, North Carolina
  • Michael Pencina
    Duke Clinical Research Institute, Duke Health, Durham, North Carolina
  • Robert D. Toto
    University of Texas Southwestern Medical Center, Dallas
  • Christoph Wanner
    Division of Nephrology, Department of Medicine, Würzburg University Clinic, Würzburg, Germany
  • Bernard Zinman
    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
  • Hans Juergen Woerle
    Ulm University, Ulm, Germany
  • David Baanstra
    Boehringer Ingelheim, Alkmaar, the Netherlands
  • Egon Pfarr
    Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
  • Sven Schnaidt
    Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
  • Thomas Meinicke
    Boehringer Ingelheim International GmbH, Biberach, Germany
  • Jyothis T. George
    Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
  • Maximilian von Eynatten
    Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
  • Darren K. McGuire
    University of Texas Southwestern Medical Center, Dallas

Bibliographic Information

Other Title
  • The CARMELINA Randomized Clinical Trial

Journal

  • JAMA

    JAMA 321 (1), 69-, 2019-01-01

    American Medical Association (AMA)

Citations (44)*help

See more

Details 詳細情報について

Report a problem

Back to top